Remission of Refractory Intestinal Behcet's Disease with Infliximab.
10.4078/jkra.2007.14.1.61
- Author:
Woo Young CHOI
1
;
Jung Yoon CHOE
;
Joo Hyoung LEE
;
Chang Jin SEO
;
Keun Woo PARK
;
Ji Young KIM
;
Sung Hoon PARK
;
Jin Hyang SHIN
Author Information
1. Department of Internal Medicine, Catholic University of Daegu, School of Medicine, Daegu, Korea. jychoe@cu.ac.kr
- Publication Type:Case Report
- Keywords:
Behcet's disease;
Gastrointestinal involvement;
Infliximab
- MeSH:
Colon;
Fistula;
Humans;
Infliximab;
Vasculitis
- From:The Journal of the Korean Rheumatism Association
2007;14(1):61-65
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Behcet's disease is a chronic, relapsing vasculitis of unknown origin that affects nearly all organs. The most frequent extra-oral sites of gastrointestinal involvement are the ileocecal lesion and the colon. The lesions are typically resistant to medical treatment and frequently recur with surgical treatment. We describe a patient who had intestinal Behcet's disease complicated perforation and enterocutanous fistula with a good response to infliximab.
